SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of NPS Pharmaceuticals, Inc.

BALA CYNWYD, Pa., Jan. 13, 2015 /PRNewswire/ -- Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of NPS Pharmaceuticals, Inc. ("NPS" or "the Company") (Nasdaq-NPSP-News) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Shire plc.("Shire").

Click here to learn more about the investigation http://brodsky-smith.com/876-npsp-nps-pharmaceuticals-inc.html, or call 877-534-2590. There is no cost or obligation to you.

Under the terms of the transaction, NPS shareholders will receive $46.00 in cash for each share of NPS stock they own. The investigation concerns whether the Board of   NPS breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether Shire is underpaying for NPS shares. The transaction may undervalue NPS  given the market for the Company's GATTEX/REVESTIVE drug for injection that is approved to treat adults with short bowel syndrome.  In addition, prior to the announcement, an analyst had set a $50.00 per share price target on NPS stock.

If you own shares of NPS common stock and wish to discuss the legal ramifications of  the investigation, or have any questions, you may e-mail  or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 510, Bala  Cynwyd, PA  19004, by e-mail at  [e-mail], by visiting http://brodsky-smith.com/876-npsp-nps-pharmaceuticals-inc.html, or calling toll  free 877-LEGAL-90.

Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert--brodsky--smith-llc-announces-investigation-of-the-board-of-directors-of-nps-pharmaceuticals-inc-300020294.html

SOURCE Brodsky & Smith, LLC

Copyright 2015 PR Newswire